DR PHARMA
Board
1 director, since incorporationDirector
appointed by deed of 21-12-2021
term without a fixed end
listed in the 2025 annual accounts, filed on 10-06-2026
Mandates through the years
1 name, the dashed line is todayBoard
Mandates as a list
- REGNIER Cyrille Jean Jules Bastien Ghislain
- Director, appointed by deed of 21-12-2021, still in office
Control
Founders
REGNIER Cyrille Jean Jules Bastien Ghislain, DUMONCEAUX Camille Bénédicte Pauline
This company
DR PHARMA
Equity €591,990
Profit €112,169 in 2025
Capital
- Contribution
- €5,000
- Shares
- 100
- Contribution per share
- €50
- Equity per share
- €5,920 in 2025
- Source
- deed of 21-12-2021
Articles of association
deed of 21-12-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Frais généraux, majorité absolue voix”
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant et moitié acquéreurs au prorata si plusieurs, prix notification initiale ou expert si contestation”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 21-12-2021 ↗
- REGNIER Cyrille Jean Jules Bastien Ghislain 50 shares (50%) · €2,500
- DUMONCEAUX Camille Bénédicte Pauline 50 shares (50%) · €2,500